Kuros Biosciences Ltd. (CSBTF)
26.99
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Kuros Biosciences EPS Diluted (Quarterly)
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2013 | -33.09 |
| September 30, 2013 | -27.23 |
| June 30, 2013 | -28.51 |
| March 31, 2013 | -19.26 |
| December 31, 2012 | -16.03 |
| September 30, 2012 | -28.70 |
| June 30, 2012 | -21.51 |
| March 31, 2012 | 34.85 |
| December 31, 2011 | -37.44 |
| September 30, 2011 | -96.05 |
| June 30, 2011 | -70.72 |
| March 31, 2011 | -73.32 |
| December 31, 2010 | -88.41 |
| September 30, 2010 | -75.55 |
| June 30, 2010 | 163.30 |
| March 31, 2010 | -46.49 |
| December 31, 2009 | -15.39 |
| September 30, 2009 | -68.79 |
| June 30, 2009 | -71.91 |
| March 31, 2009 | -133.15 |
| December 31, 2008 | 7.089 |
| September 30, 2008 | -132.46 |
| June 30, 2008 | -68.20 |
| Date | Value |
|---|---|
| March 31, 2008 | -124.61 |
| December 31, 2007 | -103.08 |
| September 30, 2007 | 236.47 |
| June 30, 2007 | -147.05 |
| March 31, 2007 | -60.93 |
| December 31, 2006 | -89.55 |
| September 30, 2006 | -96.06 |
| June 30, 2006 | -94.57 |
| March 31, 2006 | -86.95 |
| December 31, 2005 | -75.56 |
| September 30, 2005 | -85.28 |
| June 30, 2005 | -50.11 |
| March 31, 2005 | -103.49 |
| December 31, 2004 | -95.28 |
| September 30, 2004 | -86.43 |
| June 30, 2004 | -70.64 |
| March 31, 2004 | -58.25 |
| December 31, 2003 | -77.90 |
| September 30, 2003 | -57.38 |
| June 30, 2003 | -83.00 |
| March 31, 2003 | -80.21 |
| December 31, 2002 | -227.78 |
| September 30, 2002 | -74.54 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Molecular Partners AG | -0.4479 |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 2.050 |
| AC Immune SA | 0.026 |
EPS Diluted (Quarterly) Related Metrics
| Enterprise Value | 1.062B |
| Earnings Yield | 0.83% |
| Operating Earnings Yield | 0.97% |
| Normalized Earnings Yield | 0.8299 |